Liu-Wei-Di-Huang-Wan was shown to prevent the progression of renal fibrosis by inhibiting the NF-κB pathway in rats with diabetic nephropathy (Xu et al., 2017). This evidence concerns the gene NFKB1 and diabetic kidney disease.